Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06596122
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
Vitamin D Supplementation in Breast Cancer Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Effect of Vitamin D Supplementation in Breast Cancer Patients Receiving Taxane-based Chemotherapy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is a randomized clinical trial aimed at exploring the neuroprotective effect of vitamin D3 Cholecalciferol supplementation in conjunction with paclitaxel-based chemotherapy among breast cancer patients with vitamin D insufficiency or deficiency
Detailed Description:
This study is a two-arm randomized controlled trial with 132 participants evenly randomized into an intervention group and a control group Both groups are scheduled to receive Adriamycin-Cyclophosphamide followed by paclitaxel AC-T chemotherapy protocol The intervention group will undergo paclitaxel-based chemotherapy along with vitamin D replacement therapy Conversely the control group will follow the AC-T protocol without the addition of vitamin D replacement therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None